| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 29th December 2020 | Troy A. Ignelzi | 2,131 | Exercise of derivative | $9.20 | $19,605.20 |
| 29th December 2020 | Troy A. Ignelzi | 5,869 | Exercise of derivative | $9.20 | $53,994.80 |
| 18th December 2020 | Steven M Paul | 15,000 | Open or private sale | $140.00 | $2,100,000.00 |
| 18th December 2020 | Steven M Paul | 15,000 | Exercise of derivative | $9.30 | $139,500.00 |
| 14th December 2020 | Atul Pande | 5,714 | Open or private sale | $92.64 | $529,344.96 |
| 14th December 2020 | Andrew Craig Miller | 12,500 | Exercise of derivative | $2.92 | $36,500.00 |
| 14th December 2020 | Atul Pande | 5,714 | Exercise of derivative | $2.92 | $16,684.88 |
| 10th December 2020 | Andrew Craig Miller | 3,571 | Open or private sale | $94.82 | $338,602.22 |
| 10th December 2020 | Andrew Craig Miller | 1,429 | Open or private sale | $94.82 | $135,497.78 |
| 10th December 2020 | Andrew Craig Miller | 1,429 | Exercise of derivative | $9.20 | $13,146.80 |
Karuna Therapeutics
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company develops treatments for people afflicted with schizophrenia.
Ticker: KRTX
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1771917
Employees: 19
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
DXP Enterprises Reports Third Quarter 2020 Results
6th November 2020
17 Arrested For Running Fake Call Centre In Delhi: Police
6th November 2020
Ubiquiti Inc. Reports First Quarter Fiscal 2021 Financial Results
6th November 2020